On Friday, the Centers for Disease Control and Prevention approved Moderna’s coronavirus vaccine for use in kindergartners through high school students.
The CDC approval allows Modern to join Pfizer’s shot, which was approved for similar age groups last year.
CDC director Rochelle Walensky said in a statement that the Moderna vaccine is a second safe and effective vaccine for children ages 6 through 17 years.
“Vaccinating this age group can provide greater confidence to families that their children and adolescents participating in childcare, school, and other activities will have less risk for serious COVID-19 illness,” Walensky said.
The CDC recommends using two doses of Moderna’s 50-microgram shot for children from 6 to 11 years old and two doses of its 100-microgram shot for those 12 to 17 years of age — the same dosage adults currently receive.
According to reports, authorization of Moderna’s shot for those aged 6 to 17 faced delays sparked by concerns about heart complications that have been seen in a relatively small number of recipients, particularly among young men.